Newsroom
Subscribe
Contact
About us
About us
Company Overview
Team
Careers
Our Science
Our Science
Pipeline
Pipeline
Investors
Investors
Investor Overview
Press Releases
Events + Presentations
Company Information
SEC Filings
Stock Information
Corporate Governance
News Alerts
In the News
Jazz Leaps into Epilepsy with $7.2B Buyout of Cannabinoid Drugmaker GW Pharma [Fierce pharma]
February 4, 2021
https://www.fiercepharma.com/pharma/jazz-eyes-epilepsy-market-7-2b-buyout-cannabinoid-drugmaker-gw
